Active Not RecruitingPhase 3

Use of Blinded Tapering for Hypnotic Discontinuation

NCT04050176•National Jewish Health

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Hypnotic Dependence Among Those With Insomnia

Interventions

Hypnotic Medication Open-Label Taper

Hypnotic Medication Blinded Taper

Locations

1

United States

Locations (1)

National Jewish Health

Denver, Colorado, United States

Key Dates

Start Date

December 16, 2019

Primary Completion Date

December 31, 2024

Completion Date

June 30, 2026

Last Updated

February 24, 2025

Sponsors

Lead Sponsor

National Jewish Health

Collaborators

National Institute on Drug Abuse (NIDA)

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 24, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions